Press Release

ZEISS Announces Collaborative Research Partnership with
Max Planck Florida Institute for Neuroscience

LSM 980 NLO confocal microscope with GRIN lenses in combination with Airyscan 2 to be used in deep brain functional neuroscience research

Zeiss announces that it has formed a research collaboration partnership with the Max Planck Florida Institute for Neuroscience (MPFI). Using an LSM 980 NLO next generation confocal microscope supplied by ZEISS, MPFI will investigate using implanted GRadient INdex (GRIN) lenses in combination with the Airyscan 2 area detector for deep brain functional neuroscience research.

Airyscan 2, an area detector with 32 concentrically arranged detection elements, provides a unique combination of gentle super-resolution imaging and high sensitivity. Combining Airyscan with GRIN lens technology enables increased resolution and signal-to-noise while imaging regions of the brain that are unreachable with traditional in vivo microscopy.

“We are excited to announce this new collaborative research partnership, which will provide ZEISS equipment to MPFI researchers for explorative research for publication and IP generation,” said Joseph Huff, ZEISS Microscopy’s Head of Marketing, North America. “The partnership will increase both partners’ application and methodology know-how and best practices. In addition, information gained will be used to inform ZEISS’s solution and product creation process.”

MPFI, part of the world-renowned Max Planck Society, brings together exceptional neuroscientists from around the world to answer fundamental questions about brain development and function and to develop new technologies that make groundbreaking scientific discoveries possible. According to Dr. Nicolai Urban, MPFI’s Microscopy Specialist, “The Airyscan 2’s impressive boost to speed and sensitivity has greatly benefited our research in multiple areas. Working together with ZEISS experts will allow us to explore and push the boundaries of implementing this technology in equally daunting and exciting imaging conditions.”

Max Planck Florida is part of the world-renowned Max Planck Society, and the only institute of its kind located in North America. The organization’s imaging core is internationally recognized as a leader in cutting-edge neuroscience microscopy.

As part of the partnership, ZEISS and Max Planck Florida will co-sponsor, host, and support academic research workshop activities and internal training focusing on deep brain functional imaging using ZEISS Airyscan and other ancillary technology. Max Planck Florida research staff will present lectures about their ongoing research and best practices for functional neuroscience imaging.

Press contact
Kristin Nugent
McNeil, Gray & Rice
Tel. 617-367-0100 x148
E-Mail: kristin .nugent @mgr1 .com

ZEISS is an internationally leading technology enterprise operating in the fields of optics and optoelectronics. In the previous fiscal year, the ZEISS Group generated annual revenue totaling more than 5.8 billion euros in its four segments Industrial Quality & Research, Medical Technology, Consumer Markets and Semiconductor Manufacturing Technology (status: 30 September 2018).

For its customers, ZEISS develops, produces and distributes highly innovative solutions for industrial metrology and quality assurance, microscopy solutions for the life sciences and materials research, and medical technology solutions for diagnostics and treatment in ophthalmology and microsurgery. The name ZEISS is also synonymous with the world's leading lithography optics, which are used by the chip industry to manufacture semiconductor components. There is global demand for trendsetting ZEISS brand products such as eyeglass lenses, camera lenses and binoculars.

With a portfolio aligned with future growth areas like digitalization, healthcare and Smart Production and a strong brand, ZEISS is shaping the future far beyond the optics and optoelectronics industries. The company's significant, sustainable investments in research and development lay the foundation for the success and continued expansion of ZEISS' technology and market leadership.

With approximately 30,000 employees, ZEISS is active globally in almost 50 countries with around 60 of its own sales and service companies, more than 30 production sites and around 25 development sites. Founded in 1846 in Jena, the company is headquartered in Oberkochen, Germany. The Carl Zeiss Foundation, one of the largest foundations in Germany committed to the promotion of science, is the sole owner of the holding company, Carl Zeiss AG.

Further information is available at

ZEISS Research Microscopy Solutions

ZEISS Research Microscopy Solutions is the world's only one-stop manufacturer of light, electron, X-ray and ion microscope systems and offers solutions for correlative microscopy. The portfolio comprises of products and services for life sciences, materials and industrial research, as well as education and clinical practice. The unit is headquartered in Jena. Additional production and development sites are located in Oberkochen, Göttingen and Munich, as well as in Cambridge in the UK, and in Peabody, MA and Pleasanton, CA in the USA. ZEISS Research Microscopy Solutions is part of the Industrial Quality & Research segment.

About the Max Planck Florida Institute for Neuroscience
The Max Planck Florida Institute for Neuroscience (MPFI), a not-for-profit research organization, is part of the world-renowned Max Planck Society, Germany’s most successful research organization with over 80 institutes worldwide. Since its establishment in 1948, 20 Nobel laureates have emerged from the ranks of its scientists, including two just announced in 2020. As its first U.S. institution, MPFI provides exceptional neuroscientists from around the world with the resources and technology to answer fundamental questions about brain development and function. MPFI researchers employ a curiosity-driven approach to science to develop new technologies that make groundbreaking scientific discoveries possible. For more information, visit